BIO TAPS NEW CEO: “The Biotechnology Innovation Organization has chosen biotech executive John Crowley to helm the industry group and lead its 1,000 members, succeeding interim CEO Rachel King on March 4,” POLITICO’s Megan Wilson reports. — “Crowley is the founder of Amicus Therapeutics, a company focused on treatments and therapies for rare diseases. His resume also includes serving as a Navy intelligence officer and he was once a Republican favorite to challenge the late Sen. Frank Lautenberg (D-N.J.).” — “BIO has been without a permanent CEO since last October when Michelle McMurry-Heath stepped down after clashes with its board. The prominent biotech trade group has spent $6.8 million on lobbying from January through September, according to disclosures,” championing an effort to make “tweaks to drug policies in the Inflation Reduction Act, including exempting medications that treat one or more rare diseases from Medicare drug price negotiations. Lawmakers recently introduced a bipartisan bill to make the fix, known as the ORPHAN Cures Act.” JEWISH ADVOCACY GROUPS LAUNCH RAPID RESPONSE OPERATION: Some of the most prominent Jewish advocacy groups in the country are launching a new coordinated effort to counter what they see as misinformation about Israel’s ongoing war with Hamas. The 10/7 Project is named for the date of the attack by Hamas and is being led by the American Jewish Committee, the Jewish Federations of North America, the Anti-Defamation League, the American Israel Public Affairs Committee and the Conference of Presidents of Major American Jewish Organizations. — The coalition will feature an “aggressive” rapid response effort “to combat misinformation and inaccurate reporting about the Israel-Hamas conflict and continue shining a light on the victims and hostages” of the Oct. 7 attacks, the Jewish Federations’ Eric Fingerhut said in a statement. That effort will also include a daily newsletter and a media campaign that will seek to elevate reporting the groups view as accurate and call out coverage of the war that they see as biased. — A bipartisan group of public affairs firms will support the effort in order to give the coalition “eyes and ears everywhere,” a spokesperson affiliated with the project told PI: On the left, it has SKDK, the Democratic firm co-founded by President Joe Biden adviser Anita Dunn, and CKR Solutions, co-founded by former Hillary Clinton aide Philippe Reines, and on the right, it has GOP consultancy OnMessage. Josh Isay, SKDK’s former chief executive, will be executive director of the 10/7 Project. TWO ROADS DIVERGED: “Tech leaders have been vocal proponents of the need to regulate artificial intelligence, but they’re also lobbying hard to make sure the new rules work in their favor. That’s not to say they all want the same thing,” The Associated Press’ Matt O’Brien reports. — “Facebook parent Meta and IBM on Tuesday launched a new group called the AI Alliance that’s advocating for an ‘open science’ approach to AI development that puts them at odds with rivals Google, Microsoft and ChatGPT-maker OpenAI. These two diverging camps — the open and the closed — disagree about whether to build AI in a way that makes the underlying technology widely accessible. Safety is at the heart of the debate, but so is who gets to profit from AI’s advances.” — “The AI Alliance — led by IBM and Meta and including Dell, Sony, chipmakers AMD and Intel and several universities and AI startups — is ‘coming together to articulate, simply put, that the future of AI is going to be built fundamentally on top of the open scientific exchange of ideas and on open innovation, including open source and open technologies,’” IBM executive Darío Gil told the AP. — Critics of the idea point to the threat of an AI system that eventually becomes so powerful that it would be dangerous for it to be accessible to the public, especially without regulatory guardrails, an argument that others dismiss as fearmongering. ANTITRUST GROUPS PUSH FOR A STRONGER HAND ON AI: A coalition of tech and competition watchdog groups wants the Biden administration to do more when it comes to preventing the usual tech giants from extending their dominance and influence to the AI sector amid the global scramble to stand up a regulatory framework. — “While we certainly welcome the Administration’s recent executive order on AI, we are concerned that the EO does not sufficiently address the competition concerns posed by these technologies,” the Tech Oversight Project, American Economic Liberties Project, Accountable Tech, Demand Progress, the Institute for Local Self-Reliance and more said in a letter Monday to National Economic Council Director Lael Brainard. — Going forward, the groups added, “we urge you to issue further policy measures aimed at preventing AI from being wielded as a tool of monopolists.” From tech companies’ own AI ventures like Google’s Bard chatbot and investments in AI startups — like Microsoft’s minority stake in OpenAI — the groups called on the administration to issue additional guidance on competition in the AI space and to channel more investment toward public infrastructure and open source software or the use of other tools. — “Though many initiatives included in the EO are laudable, we believe that it is critical for the Administration to combat the harms posed by AI by taking on the monopolists seeking to leverage these harms for their own gain,” the groups argued. “Time and time again, Big Tech has shown that it will fight even modest efforts to minimize harms caused by their dominance.” AS WE WERE SAYING: “Google wants to make your cell phone a ‘doctor in your pocket’ that relies on the company’s artificial intelligence. But first, the tech giant will need to convince skeptical lawmakers and the Biden administration that its health AI isn’t a risk to patient privacy and safety — or a threat to its smaller competitors,” POLITICO’s Ruth Reader writes. NARRATIVE ADDS CISA SPOX: Avery Monsees has left DHS, where she was press secretary and senior adviser for public affairs at the Cybersecurity and Infrastructure Security Agency, to join Narrative Strategies as a director. Prior to joining the Biden administration, Monsees was a comms and legislative aide for Sen. Tom Carper (D-Del.). — Monsees is one of four recent hires at Narrative, which has seen its staff double in the past year. Jack Turman is joining the firm as a strategic communications manager from CBS News, Evelyn Humphrey joined as operations manager from the Hill in October, and former interns Ben Bissen and Valeria Fernandez have joined the firm full-time as strategic communications associates.
|
Comments
Post a Comment